chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Aches and pains all over; Fever of 101.5 Fahrenheit; Nausea; Very tired; Soreness in the area of the shot, achy in the shot area; Swelling beside her clavicle; swollen lymph node; Lymph node was tender; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9264), via an unspecified route of administration in right upper arm, on 03Feb2021 at 03:30 PM (15:30), at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (Lot Number: EL3247) on 13Jan2021 at the age of 68 years for COVID-19 immunization. The vaccine was administered in a hospital facility. The patient had a lot of side effects after her second vaccine which was given on 03Feb2021 at 03:30 in the afternoon. That same evening (03Feb2021), the patient noticed some soreness in the area of the shot, achy in the shot area. Then the next day (04Feb2021), the patient was achy all over (aches and pains all over) in the morning and as the day went on, she got the fever of 101.5 Fahrenheit that day (04Feb2021). For the fever, the patient took paracetamol (TYLENOL) and the fever went away. It went away during the night so sometime either on 04Feb2021 or 05Feb2021. The patient did not have fever when she woke up on 05Feb2021. The patient also had nausea (feeling nauseous) which began on 04Feb2021 which resolved; that went on for about 3 days all together (unspecified). The patient was also very tired on 04Feb2021; tiredness it is not ongoing, but she does not recall when that recovered. The patient knows she had it at the same time as the aches and pains and the fever. In Feb2021, the patient noticed swelling beside her clavicle on the same side that she got the shot on, on the right side of her body. The patient went to the urgent care and it turns out she had a swollen lymph node there and it was tender (Feb2021). The patient confirmed that it was on her right side near her clavicle on the same side she got the injection, the right side. The swollen lymph nodes were not swollen anymore but they (lymph nodes) were tender around that area still. The patient did go to the urgent care on Friday (05Feb2021) due to the swelling on her clavicle. The patient did not realize it was a swollen lymph node. They did not do any testing or blood test they just looked at the area of the swelling of the lymph nodes. Swollen lymph nodes that were tender resulted in emergency room and physician office visit. The outcome of "Soreness in the area of the shot, achy in the shot area" was unknown. The patient had not recovered from "Lymph node was tender". The patient recovered from "Aches and pains all over" on 05Feb2021; and from the remaining events in Feb2021.
Chest pain, vomitting, and inflammation. Inflammation persisted following the acute event on 05OCT2022.
Patient arrived at vaccine event without his vaccination card stating he needed his second dose. Patient was given the vaccine prior to staff verifying the date of the first dose. Patient's first dose was on 7/13/2021, the second dose was give a week too soon.
Pt recv vax on 7/29/98; subsequently pt exp lymph node enlargement of left side at elbow, underarm &groin.
Atrial fibrillation event after 27 hours of second Moderna Covid-19 shot;   Atrial fibrillation event after 5 days of first Moderna Covid-19 shot.
Received Pfizer on 02/17/21 and 3/17/21. Presented to ER on 1/9/22.  Patient was coming from Manor  for evaluation of the right-sided facial droop that happened around 2:00 in  the morning, and patient had a history of hemorrhagic stroke.  He is usually  verbally responsive and able to answer the questions.  The staff reported to  the ER that the patient was yelling for help.  The patient was recently  diagnosed as COVID positive on January 1st  that he came to the emergency  room.  He is not responding very well. Was room air so only on doxycycline. Discharged on 1/13/22
vaccination adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (vaccination adverse reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (vaccination adverse reaction). At the time of the report, VACCINATION COMPLICATION (vaccination adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details were provided. No treatment information was mentioned.
8APR95 family called EMS, lips blue & shaking for approx 2 mins; 1513 EMS arrived; pt irritable & lethargic; skim warm, color good; drainage from both eyes; wet breath sounds on rt; 02 sat 89% R/A; put on 02; t101.4; crying;
This case was reported by a consumer via call center representative and described the occurrence of shivering in a 75-year-old female patient who received Shingrix for prophylaxis. Previously administered products included Shingrix with an associated reaction of injection site pain (1st dose received on 1st June 2018, refer case US2018185583). Concurrent medical conditions included wet macular degeneration and injection site pain. On 19th September 2018, the patient received the 2nd dose of Shingrix. On 19th September 2018, less than a day after receiving Shingrix, the patient experienced shivering, skin discoloration, boil in nose, itchy scalp and influenza-like symptoms. On 24th September 2018, the outcome of the shivering and influenza-like symptoms were recovered/resolved. On an unknown date, the outcome of the skin discoloration, boil in nose and itchy scalp were not recovered/not resolved. It was unknown if the reporter considered the shivering, skin discoloration, boil in nose, itchy scalp and influenza-like symptoms to be related to Shingrix. Additional details were reported as follows: The patient was seen by her a physician. The patient planned to continue follow-up with her physician on an unknown date.
On the back of my right shoulder I have a red, raised welt that is warm to the touch and feels a bit raw. About 5 inches long and 2 inches wide. We used a cold pack and then applied some Extra Strength Benadryl Cream on it. About an hour later, it is now light red and less noticeable. Still feels a little raw.
pt recv vax; lt arm swollen & red & hot to touch area covered entire upper arm over deltoid muscle;dx w/ thimerisol rxn to DTap;tx w/ cortisone
no adverse event; expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) and NO ADVERSE EVENT (no adverse event) in a 56-year-old female patient who received mRNA-1273 (Spikevax) (batch no. O70H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (expired vaccine used).    Patient age was reported as 56 Year 7 Month.  Concomitant medications details were not reported by the reporter.  Reportedly, the patient at facility received Moderna vaccine between 08-Apr-2022 and 15-Dec-2022.  ID was reported as 80777027399.  Completion date provided as 19-Jul-2022  Treatment details were not reported by the reporter.
Right leg, red/swollen at injection site, given Rx for Cipro 250mg BID x 10 days.
At approx 0900 pt received second dose of anthrax vaccine, walked to check out desk to exit reported feeling lightheaded and palpitations, sat in lobby for unknow amount of time, palpitations, increased dizziness, notified staff who assisted and a PA. B/P elevated, Decreased symptoms lasted approx 50 minutes and stopped. EMS was called pt refused care and signed out AMA with Ambulance company.
Extreme exacerbation of patient's longstanding Crohns Disease. Intractable liquid diarrhea for 5 days beginning approximately 48 hours after first shot; almost constant Fever; Body Aches; Strong lower back and hip pain; Bilateral pedal edema; dehydration; inability to absorb fluids for 5 days; arm, ankle, hip, back, shoulder, and wrist joint pain; difficulty getting out of bed in the morning, or getting up from the stationary position.  Symptoms finally resolved day 7 just before I anticipated going to ED in local hospital, and were gone for two days.  Symptoms returned on day 9 following vaccination and lasted 5 additional days,  with symptoms resolving for good only on the 15th day after the initial injection.
This spontaneous report was received from a Medical Assistant, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not reported. On 02-FEB-2017, the patient was vaccinated with an expired dose of GARDASIL 9 intramuscularly, with lot # K026246 and expiration date on 28-JAN-2017 (anatomical route of vaccination not provided) for prophylaxis (expired product administered). It was reported that, no adverse effects were suffered and that no product quality issue was involved. Additional information has been requested.
Pt presented weak. Pt tested positive for c-19 on 09/30/2021. Pt placed on  Rocephin, Pt place on supplmental O2. Pt is still in hospital
Can I take a painkiller?; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Can I take a painkiller?) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Can I take a painkiller?). At the time of the report, MYALGIA (Can I take a painkiller?) outcome was unknown.
This patient was given the pediatric version of the Hep A (Havrix) vaccine when he should have been given the adult version.
pt states on Saturday morning devel redness, pain & swelling in the rt arm & rt axilla p/DT inj on friday, states it was difficult to move rt arm d/t pain & swelling;pt reported this to MD's office on 4DEC; MD advised pt to be seen;
This case was reported by a other health professional and described the occurrence of Influenza in a patient who received QIV FLUARIX. On an unknown date, the patient received FLUARIX at an unknown dose. On an unknown date, an unknown time after receiving FLUARIX, the patient experienced Influenza. On an unknown date, the outcome of the Influenza was unknown. It was unknown if the reporter considered the Influenza to be related to FLUARIX. Additional information: three patients vaccinated with FLUARIX QIV that got the Flu later in the season. MD did not have any further information at this time.
Facial swelling, swelling of eyes, red eyes with pink-eye like symptoms (itching, white discharge), difficulty swallowing, nasal congestion.
pt recvd vax 4NOV93 & 11NOV93 pt devel rash & a t104; 15NOV93 rash was macular & papular; lab eval revealed WBC count 5.2, lymphocytes 60.7, neutorphils 27.1, monocytes 5, EOS 9, hemoglobin 12.3 & hematocrit 36.5; no koplik spots;
10/04/04 itching face, broke out like little bumble bee stings all over, eyes red, some areas noted on bilateral left extremity.
Post vax, the pt developed a severe local reaction at injection site consisting of erythema, warmth, and induration.
Patient felt tightness in her throat, lightheaded and ears ringing. Patient given oral Benadryl, 20 minutes after administration, symptoms started to resolve.
Narrative: 92 yo male with PMH: Nocturia Heartburn Obesity Essential hypertension Malignant neoplasm of thyroid gland Enlarged prostate IMPOTENCE, ORGANIC ORIGN Hypothyroidism Allergic rhinitis CHEST SWELLING/MASS/LUMP hx of thyroid cancer s/p partial thyroidectomy prostatectomy 12/2007, 3/4 prostate taken out s/p cholecystectomy s/p lung surgery for tumor back surgery 4/2011 hx bilateral cataract removal Pt died on 4/12/2021.Pt had received covid vaccinations on 1/29/21 & 2/26/21. There is no information or details about pt's about pt's death. Not able to access if pt's death was related to covid vaccinations. Likely death was not related to vaccination given pt's advanced age.
High fever 39-40 I took paracetamol every 2 hours and the fever was raising up  Body pain , part by part starting from the left side to the heart and going to the back and spine, knees  Lest arm is cold and heavy, I cannot move my fingers properly  and on 30/12 I did not take paracetamols but the fever continued around 37-38 and heavy body pain
broken out in hives on the right outside calf and left inside calf/both of my forearms were also broken out in hives; feeling tired; nauseated; couldn't taste/no smell or taste; no smell; This case was reported by a consumer and described the occurrence of hives in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th September 2020, the patient received the 1st dose of Shingrix. On 28th September 2020, 3 days after receiving Shingrix, the patient experienced hives, tiredness, nausea, taste loss and loss of smell. Shingrix was discontinued. On an unknown date, the outcome of the hives, tiredness and nausea were unknown and the outcome of the taste loss and loss of smell were not recovered/not resolved.   The reporter considered the hives, tiredness, nausea, taste loss and loss of smell to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but could be 50 or 51 years. On 28th September 2020, the patientI was feeling tired and nauseated and noticed that she was broken out in hives on the right outside calf and left inside calf. After eating soup for dinner, the patient realized she could not taste everything she was eating.  The patient immediately panicked and thought she had COVID. The patient got tested on 30th September 2020 and results were negative on 3rd October 2020. By that time both of the patient's forearms were also broken out in hives. Since the patient got tested negative for COVID, a nurse told the patient that all of her side effects were more than likely from Shingrix vaccine. The patient showed the pharmacist and she said not to get the second vaccine. The patient wanted to see if anyone else had reported the no smell or taste, it had been almost three weeks and the patient still could not. The patient looked over the list of drugs that might interact on website, but she did not take any that were listed.
I woke up  on 11/8 with a swollen uvula, swollen lips, swollen tip of my tongue. And trouble swallowing.   Swelling lasted approximately 2 or  3 hours.  Swlf administered 2 benadryl and 1 zyrtec.  Symptoms did not worsen. Felt discomfort and minor swelling in lips and uvula for many days after.  Self administered zyrtec as needed.
Fever, chills, aches, half of a softball size lump at injection site, intense itching and burning at injection site, hot at injection site
Incomplete dose; A spontaneous report was received from a pharmacist concerning an unidentified patient who received Moderna's COVID-19 Vaccine (mRNA-1273)and experienced incomplete dose.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 04 Jan 2021, approximately 0 days prior to the onset of the event, the patient received their first/second of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On 04 Jan 2021, the vaccinating pharmacist reported when they pulled the needle of the syringe from the patient's arm, it seemed like the entire dose of vaccine came out. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.  The event, while pulling the needle of the syringe from patient's arm, it seems the entire dose of the vaccine came out, was considered resolved on 04 Jan 2021.; Reporter's Comments: This report refers to the case of a patient who during administration of Moderna's mRNA-1273 vaccine (lot # unknown, Exp. Unknown) when they pulled the needle of the syringe from the patient's arm, it seemed like the entire dose of vaccine came out. There were no reported AEs associated with this case of when they pulled the needle of the syringe from the patient's arm, it seemed like the entire dose of vaccine came out.
Woke up with moderate chills around 430am on 05FEB2021 and had difficulty sleeping until getting out of bed at 800am. Felt instant dizziness, fatigue, headache, and ear ringing when I stood up. Felt hot at first, then chilled, and continued to switch between hot and cold. These symptoms lasted for about 5 hours with varying levels of severity. My temperature high was 98.3 F according to the infrared forehead thermometer I used throughout the duration of symptoms.
This spontaneous case was reported by a patient family member or friend and describes the occurrence of MYOCARDIAL INFARCTION (brother had a heart attack after getting the vaccine) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYOCARDIAL INFARCTION (brother had a heart attack after getting the vaccine) (seriousness criterion medically significant). At the time of the report, MYOCARDIAL INFARCTION (brother had a heart attack after getting the vaccine) outcome was unknown. The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown. No concomitant medication was reported. No treatment medication was reported. Company Comment: This spontaneous case concerns a male patient, of unknown age, with no medical history reported, who experienced the unexpected, serious (medically significant) AESI of myocardial infarction unknown number of days after receiving an unspecified dose of the mRNA-1273 vaccine on an unspecified date. The start date of the event was not provided. It was reported that the patient experienced a heart attack after vaccination. No further details were provided. The outcome of the event was unknown at the time of the report. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report. This case was linked to MOD-2022-594901 (Patient Link). Reporter did not allow further contact. Sender's Comments: This spontaneous case concerns a male patient, of unknown age, with no medical history reported, who experienced the unexpected, serious (medically significant) AESI of myocardial infarction unknown number of days after receiving an unspecified dose of the mRNA-1273 vaccine on an unspecified date. The start date of the event was not provided. It was reported that the patient experienced a heart attack after vaccination. No further details were provided. The outcome of the event was unknown at the time of the report. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.
No other adverse events reported; an improperly stored dose of VARIVAX was administered to a patient; This spontaneous report was received from pharmacist and refers to a patient of unknown age and gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 05-APR-2022, an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 1 dose, lot #T012551, expiration date: 10-APR-2022 (strength and route of administration were not provided) was administered to the patient for prophylaxis. The vaccine was exposed to temperature of 46 Fahrenheit for 144 hours. No previous temperature excursion was reported. No further information provided. No other adverse events reported. No product quality complaint.
Symptoms peaked between 10/08/2021 and 10/19/2021 with sciatic attack on left rear and intense pain above left knee. It was so bad at times, that I could not walk or even maintain my balance. I started using aspercream and Voltarin on my left rear left thigh, and left shoulder and arm. Also started taking 3 naproxen to relieve pain. Symptoms gradually decreased, so a reduced the naproxen to none on 10/20/21, but continued with the aspercream through 10/22/21. I believe I got the booster shot too soon after the first two vaccinations.
2 cm cystic lesion, mobile at injection site of MMR vaccine. Appeared 24 hours after injection. Treat with BENADRYL and NSAIDS.
During our 3rd visit to the facility this patient was registered to receive their second dose of the Pfizer COVID-19 Vaccine. The Nurse did not produce the vaccination record card. We administered the dose as requested. Upon returning to the pharmacy to process the VAR our records indicated that the pt received 2 previous doses at previous clinics.
Her arm got itchy; The injection mark got bigger; This is a spontaneous report from a Pfizer sponsored program received from a contactable consumer (patient). A female patient of an unspecified age received the second dose of BNT162B2 Pfizer-BioNTech COVID-19 Vaccine, via an unspecified route of administration, on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that, after the second shot, her arm got itchy and the injection mark got bigger. The events onset date and outcome were unknown at the time of the report.  Information on lot/batch number has been requested.
Patient received first dose of Pfizer vaccination. After couple of minutes, when asked how he feels he stated he feels dizzy. Cold water was given to him and ice packs were used. Patients eyes rolled back and he passed out twice . Asked to call 911. Patient regains consciousness and states he feels fine. When asked him what happened he said he passed out and this happens to him with every vaccines he receives. BP reading at 2:11pm 150/84 mm Hg/mm. Patient stated he feels much better now. Blood pressure reading 2:20pm  132/82 Hg/mm. EMT now on site to assess the patient.  Patient is good now and doesn?t need to be transported. Entire team present at the site. Proper PPE was used.
This case is a part of cluster of 2 cases (same reporter and vaccine) and is linked to case number 2013SA136389. Initial report received from a healthcare professional on 26 December 2013: A female patient (age between 21-50), had received a dose of FLUZONE ID, (batch number, dose number, route and site of administration not reported) on an unspecified date of November 2013. The patient had no illness at the time of vaccination and pre-existing medical conditions were not available. It was reported that the patient was suspected to have H1N1 influenza on 24 December 2013. Laboratory investigations and corrective treatments were not reported. At the time of this report, the patient had not recovered. Documents held by sender: none.
SECOND MODERNA DOSE ADMINISTERED TO AN UNDERAGE PATIENT WHO RECEIVED HER FIRST DOSE WITH US ON 03-09-21